DiscoverMedscape InDiscussion: Multiple SclerosisCOVID-19 and MS Patients: Where Do We Go From Here?
COVID-19 and MS Patients: Where Do We Go From Here?

COVID-19 and MS Patients: Where Do We Go From Here?

Update: 2022-10-05
Share

Description

Agoraphobia, online yoga, pregnancy, and vaccines are all on the table as Drs Anne Cross and Scott Newsome discuss the COVID-19 pandemic and how it affects their patients with MS.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/977031). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.

Resources

Coronavirus Disease 2019 (COVID-19) https://emedicine.medscape.com/article/2500114-overview

Multiple Sclerosis https://emedicine.medscape.com/article/1146199-overview

COViMS Registry https://www.covims.org/

An Italian Programme for COVID-19 Infection in Multiple Sclerosis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191287/

Paxlovid Emergency Use Authorization https://labeling.pfizer.com/ShowLabeling.aspx?id=16474

Bebtelovimab Fact Sheet for Healthcare Providers https://www.fda.gov/media/156152/download

Remdesivir Prescribing Information https://www.gilead.com/-/media/files/pdfs/medicines/covid-19/veklury/veklury_pi.pdf

Evusheld Fact Sheet for Healthcare Providers https://www.fda.gov/media/154701/download

New Diagnosis of Multiple Sclerosis in the Setting of mRNA COVID-19 Vaccine Exposure https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656147/

COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407145/

Neuro-Ophthalmologic Manifestations of Multiple Sclerosis https://emedicine.medscape.com/article/1214270-overview

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

COVID-19 and MS Patients: Where Do We Go From Here?

COVID-19 and MS Patients: Where Do We Go From Here?